Viveca Ritsinger

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Chronic Kidney Disease

Glycemic Control

Top Venues

Diabetes & vascular disease research

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan Eriksson, Anna Norhammar
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study. BMJ open 13 (4) (2023)
Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan Eriksson, Anna Norhammar
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study. BMJ open 13 (4) (2023)
Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan Eriksson, Anna Norhammar
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study. BMJ open 13 (4) (2023)
Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan Eriksson, Anna Norhammar
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study. BMJ open 13 (4) (2023)
Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan Eriksson, Anna Norhammar
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study. BMJ open 13 (4) (2023)
Viveca Ritsinger, Bo Lagerqvist, Pia Lundman, Emil Hagström, Anna Norhammar
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry. Diabetes & vascular disease research 17 (6) (2021)
Viveca Ritsinger, Emil Hagström, Bo Lagerqvist, Anna Norhammar
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes. Journal of the American Heart Association 10 (22) (2021)
Viveca Ritsinger, Jens Jensen, Daniel Ohm, Elmir Omerovic, Sasha Koul, Ole Fröbert, David Erlinge, Stefan James, Bo Lagerqvist, Anna Norhammar
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study. Diabetes & vascular disease research 16 (6) (2019)
Viveca Ritsinger, Christel Hero, Ann-Marie Svensson, Nawzad Saleh, Bo Lagerqvist, Katarina Eeg-Olofsson, Anna Norhammar
Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report. Diabetes care 41 (4) (2018)